With the growing understanding of complex diseases, the focus of drug discovery has shifted from the well-accepted "one target, one drug" model designed towards a single target, to a new "multi-target, multidrug" model, aimed at systemically modulating multiple targets. In this context polypharmacology has emerged as a new paradigm to overcome the recent… (More)
[This corrects the article DOI: 10.1371/journal.pone.0162407.].
The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based… (More)
Macrocyclic Organo-Peptide Hybrids (MOrPHs) can be prepared from genetically encoded polypeptides via a chemoselective and catalyst-free reaction between a trifunctional oxyamino/amino-thiol synthetic precursor and an intein-fusion protein incorporating a bioorthogonal keto group.